Operational blind spots cost margins and elevate risks for manufacturers. We explore how teams can see these familiar challenges more clearly and solve them more efficiently.

Even after numerous FDA warnings, the agency hasn’t stopped Empower Pharmacy from producing drugs at a scale rarely — if ever ...

KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery ...

Many smaller manufacturers assume they are already behind. But in truth, most of the industry is still early in the AI ...

Texas recently launched an investigation into Lululemon, alleging that the clothes may contain PFAS. Experts explain how PFAS ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. David Kindness is a Certified Public ...

Abstract: Reinforcement learning (RL) has been widely used in recent years to solve combinatorial optimization problems; however, it has some limitations when solving such problems with practical ...

A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested – and thus could not prove – whether the products were sterile. These ...

A Pennsylvania plant run by the company, ByHeart, was shut down this year after inspectors found mold, a leaking roof and more than 2,500 dead insects in a food production area. By Christina Jewett ...

Abstract: The Internet of Things (IoT) represents a transformative convergence of traditional manufacturing systems with advanced information technologies, collectively referred to as smart ...

Former President Barack Obama's office has released a statement after President Donald Trump accused the Democrat and members of his administration of committing "treason" by allegedly manufacturing ...

The predominance of manufacturing process patents asserted in litigation by originator biologics companies against would-be biosimilar entrants has resulted in a number of Congressional and ...